Skip to main content
| News

Basel areas hold promise for investors

28.11.2019

Substantial efforts are underway in Basel to develop new areas and create space for people and companies. The efforts were welcomed by investors at the 17th Basler Investorengespräch.

The project Nordspitze exists for the area Dreispitz Nord (visualization: Herzog & de Meuron)

The 17th Basler Investorengespräch was held at the Kunstmuseum in Basel, according to the canton of Basel-Stadt. Executive Council President Elisabeth Ackermann welcomed 140 invited guests from across Switzerland who had sought to find out about the development of areas in Basel.

Occupying a total of 113 hectares, the areas under transformation are in central locations. In the coming 10 to 20 years, they will be developed with new living and working quarters in Basel’s effort to prepare for growth. The projects will create space for 20,000 new inhabitants and 30,000 jobs by 2035, confirmed Member of the Government of Basel-Stadt Hans-Peter Wessels in his speech.

Member of the Government Eva Herzog spoke about the research and administration site Areal Rosental Mitte, which is currently being transformed into a public quarter. There are plans to connect work with research and living space here, granting development opportunities to both companies in Basel and companies moving to the region. Lukas Ott, who heads cantonal and urban development in Basel-Stadt, also spoke about the variety of development across the areas. He said, Basel would do well to “develop its valuable transformation spaces gradually, flexibly and in a variety of ways”.

The event was rounded off by a panel about development in a rapidly changing market. Participants included cantonal architect Beat Aeberhard; the director of Immobilien Basel-Stadt, Rolf Borner; the head of development at SBB Immobilien, Susanne Zenker; and the CEO of Central Real Estate Basel AG, Andreas Fürst.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

South Korean pharma firms show interest in the Basel Area

Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...

Read More
Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

KetoSwiss secures capital increase of 4 million dollars

KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based startup develops products to alleviate neurological...

Read More
Basel Area Business & Innovation, Invest, Life Sciences / biotech

Escientia Switzerland becomes Primopus

The Indian company Deccan Fine Chemicals is acquiring Escientia Switzerland and renaming it as Primopus AG. The new owner announces...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Novartis investing 100 million Swiss francs in new biologics center

The pharmaceutical company Novartis is investing a sum of 100 million Swiss francs in a new competence center for biologics...

Read More
1 2 3 35

Do you have a question? We'd like to hear from you.